- Previous Close
13.93 - Open
13.89 - Bid 13.89 x 40000
- Ask 13.95 x 40000
- Day's Range
13.89 - 13.95 - 52 Week Range
12.25 - 16.25 - Volume
849 - Avg. Volume
106,950 - Market Cap (intraday)
11.251B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
28.94 - EPS (TTM)
0.48 - Earnings Date May 13, 2025
- Forward Dividend & Yield 0.48 (3.43%)
- Ex-Dividend Date Dec 30, 2024
- 1y Target Est
--
Kirin Holdings Company, Limited engages in food and beverages, alcoholic beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, soft drinks, dairy products, margarine, jams, and honey, as well as manages chain of Kirin City beer pubs. It also produces and sells pharmaceutical products. In addition, the company manufactures and sells amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals; inspection machines; and cosmetics and health foods, as well as provides logistics, accounting, human resources, and real estate services. Further, the company is involved in the development of internal information system; sales of feed; sales of the supplements; and development, manufacturing, distribution, and sale of vitamin and mineral supplements, as well as act as an insurance agent. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.
www.kirinholdings.com/jp/--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: KNBWY
View MorePerformance Overview: KNBWY
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KNBWY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KNBWY
View MoreValuation Measures
Market Cap
11.25B
Enterprise Value
16.13B
Trailing P/E
29.09
Forward P/E
11.63
PEG Ratio (5yr expected)
0.49
Price/Sales (ttm)
0.72
Price/Book (mrq)
1.43
Enterprise Value/Revenue
1.03
Enterprise Value/EBITDA
9.52
Financial Highlights
Profitability and Income Statement
Profit Margin
2.49%
Return on Assets (ttm)
3.82%
Return on Equity (ttm)
5.80%
Revenue (ttm)
2.34T
Net Income Avi to Common (ttm)
58.21B
Diluted EPS (ttm)
0.48
Balance Sheet and Cash Flow
Total Cash (mrq)
118.62B
Total Debt/Equity (mrq)
55.91%
Levered Free Cash Flow (ttm)
27.62B